COMMUNIQUÉS West-GlobeNewswire

Data on Albireo’s Odevixibat Presented at 2019 European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Annual Meeting
07/06/2019
Data support further study of odevixibat across a range of rare cholestatic liver diseases BOSTON, June 07, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease [...]
NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough
07/06/2019
NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough ~ Statistically significant and clinically relevant improvements in patient reported outcomes in refractory chronic [...]
Axsome Therapeutics Provides Update on Continued Progress at Annual Stockholders’ Meeting
07/06/2019
Placebo-controlled Phase 3 trial of AXS-05 in MDD on track to start in 2Q 2019 Topline results from both STRIDE-1 Phase 3 trial in TRD and planned placebo-controlled Phase 3 trial in MDD for AXS-05 still anticipated in [...]
Rockwell Medical Announces Adjournment of Annual Meeting of Shareholders
07/06/2019
- Adjournment solely to vote on Delaware reincorporation Proposal 3(a) - - Both leading independent advisory firms have issued favorable recommendations on proposal - WIXOM, Mich., June 07, 2019 (GLOBE NEWSWIRE) -- [...]
Nightstar Therapeutics PLC Completion of Acquisition by Biogen
07/06/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]
Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million
07/06/2019
Nightstar acquisition further bolsters Biogen’s pipeline with the addition of two mid- to late-stage clinical assets as well as preclinical programs CAMBRIDGE, Mass., June 07, 2019 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: [...]
Saniona publishes prospectus relating to the rights issue
07/06/2019
PRESS RELEASE NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION [...]
Helsinn Group supports two events with the International Society for Cutaneous Lymphomas (ISCL) at the 24th World Congress of Dermatology
07/06/2019
Helsinn Group supports two events with the International Society for Cutaneous Lymphomas (ISCL) at the 24 th World Congress of Dermatology Cutaneous Lymphoma Meeting will update on latest developments in the field [...]
Acarix participates on the Redeye Growth Day, Monday 10 June 2019
07/06/2019
Acarix participates on the Redeye Growth Day, Monday 10 June 2019 On Monday, June the 10 th at 3.40 PM, Per Persson CEO for Acarix, will be presenting the latest activities and strategic directions for Acarix. The [...]
NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough
07/06/2019
NeRRe Therapeutics announces positive findings from Phase 2b study with orvepitant in chronic cough ~ Statistically significant and clinically relevant improvements in patient reported outcomes in refractory chronic [...]
Paul Hudson to succeed Olivier Brandicourt as Chief Executive Officer
07/06/2019
Communication from the Board of Directors Paul Hudson to succeed Olivier Brandicourt as Chief Executive Officer PARIS - June 7, 2019 - At its meeting on June 6 th of 2019, Sanofi's Board of Directors unanimously [...]
Paul Hudson succèdera à Olivier Brandicourt comme Directeur Général
07/06/2019
Communication du Conseil d'Administration Paul Hudson succèdera à Olivier Brandicourt comme Directeur Général Paris - Le 7 juin 2019 - Réuni le 6 juin 2019, le conseil d'administration du Groupe Sanofi a désigné à l' [...]
Novartis announces new leader of Pharmaceuticals Business Unit
07/06/2019
Marie-France Tschudin, an experienced Novartis leader, appointed to President, Novartis Pharmaceuticals Basel, June 7, 2019 - Novartis announced today that Marie-France Tschudin, currently President, Advanced [...]
Orphazyme to prepare for filing of arimoclomol in Europe for Niemann-Pick disease Type C (NPC)
07/06/2019
Orphazyme A/S Company announcement No. 15/2019 Company Registration No. 32266355 Expected submission of Marketing Authorization Application (MAA) in H1 2020 Copenhagen, June 7, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a [...]
LaSanta Botanicals Announces Start of Commercial Production and Opening of New Pharmaceutical Laboratory
07/06/2019
CALGARY, Alberta, June 06, 2019 (GLOBE NEWSWIRE) -- LaSanta Botanicals Ltd. (the “Company” or “LaSanta“) is pleased to announce that its wholly-owned subsidiary, LaSanta SAS, has obtained approval by the national agency [...]
Achaogen, Inc. Announces Results of Auction for Substantially All Company Assets
07/06/2019
SOUTH SAN FRANCISCO, Calif., June 06, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram- [...]
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/06/2019
WALTHAM, Mass. and CRESTWOOD, Ky., June 06, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Genesis HealthCare Makes 2019 Forbes List of Best Employers in Pennsylvania
06/06/2019
KENNETT SQUARE, Penn., June 06, 2019 (GLOBE NEWSWIRE) -- Genesis HealthCare (Genesis), one of the largest post-acute care providers in the United States, today announced Forbes released its annual list of the best [...]
Grant of Restricted Stock Units and Warrants to Employees in Genmab
06/06/2019
Company Announcement Copenhagen, Denmark; June 6, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 6,464 restricted stock units and 21,343 warrants to [...]

Pages